The first companies to receive the indicative outcome of their requests for relief from next April's 'catch-up' statutory price reductions have until today to submit additional information if they want a revision.
Companies start submitting additional information in support of 'relief'
October 25, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
Rare Cancers Australia sets sights on 2026 Kosi Challenge with renewed fundraising momentum
February 15, 2026 - - Latest News -
PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations
February 15, 2026 - - Latest News -
Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 - - Latest News -
Australian medtech secures funds to advance real-time breast cancer surgery technology
February 13, 2026 - - Australian Biotech -
The Dispatched Podcast 'Week in Review' - 13 February
February 13, 2026 - - Podcast -
PBAC to reconsider broader vaccine funding after late addition to March agenda
February 13, 2026 - - Latest News -
Ten years of process 'improvements' is almost the point, says Anne Ruston
February 13, 2026 - - Latest News

